Clinical Trial Update: Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) [NA]

View source ↗

Summary

The PRIME trial is evaluating moderate versus extreme hypofractionation in prostate radiotherapy; the study is currently ACTIVE_NOT_RECRUITING according to Clin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Tata Memorial Centre | Conditions: Prostate Adenocarcinoma | NA | Status: ACTIVE_NOT_RECRUITING